This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1995-1996.
Location History:
- Osaka, JP (1995)
- Takatsuki, JP (1996)
Company Filing History:
Years Active: 1995-1996
Title: Koichi Yukishige: Innovator in Immunoenhancing Compounds
Introduction
Koichi Yukishige is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of immunology through his innovative research and development of novel compounds. With a total of 2 patents, his work focuses on enhancing immune responses and addressing hematopoietic disorders.
Latest Patents
Yukishige's latest patents include groundbreaking compounds that possess immunoenhancing activity. One of his notable inventions is a thioglycerol derivative, which is represented by a specific chemical formula. This compound is designed to be used as a prophylactic and therapeutic agent for leukocytopenia in cancer chemotherapy or radiotherapy. It also serves as an immunoenhancing agent in bone marrow transplantation therapy and the treatment of osteomyelodysplasia and aplastic anemia. Another significant patent involves 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, which are effective in improving hematopoietic disorders and treating thrombocytopenia.
Career Highlights
Koichi Yukishige is associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company known for its commitment to innovation and research. His work at Takeda has allowed him to focus on developing therapeutic agents that can significantly improve patient outcomes in various medical conditions.
Collaborations
Yukishige has collaborated with esteemed colleagues such as Seiichi Tanida and Tsuneaki Hida. These collaborations have fostered a productive research environment, leading to advancements in the field of immunology.
Conclusion
Koichi Yukishige's contributions to the development of immunoenhancing compounds highlight his dedication to improving healthcare through innovation. His patents reflect a commitment to addressing critical medical challenges, making him a notable figure in the field of immunology.